Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Geerts

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Thrombosis Research|December 2, 2008
Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolismR Selby, W Geerts, F A Ofosu, et al.
American Journal of Hematology|April 1, 1995
INR reporting in Canadian medical laboratories. Thrombosis Interest Group of CanadaM Andrew, M Brigden, J Bormanis, et al.
Chest|November 20, 1998
Prevention of venous thromboembolismG P Clagett, F A Anderson, W Geerts, et al.
Thrombosis and Haemostasis|August 1, 1995
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosisM N Levine, J Hirsh, M Gent, et al.
Intensive Care Medicine|December 14, 2004
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patientsM A Crowther, D J Cook, L E Griffith, et al.
Annals of Internal Medicine|September 1, 1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind studyA G Turpie, M Gent, R Côte, et al.
The New England Journal of Medicine|November 18, 2000
Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study GroupP Brill-Edwards, J S Ginsberg, M Gent, et al.
The Review of Scientific Instruments|March 3, 2012
Microgan electron cyclotron resonance ion source in a Van de Graaff accelerator terminalG Gaubert, C Bieth, W Bougy, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Journal of Thrombosis and Haemostasis : JTH|March 1, 2005
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosisS R Kahn, C Kearon, J A Julian, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Thrombosis Research|December 2, 2008
Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolismR Selby, W Geerts, F A Ofosu, et al.
American Journal of Hematology|April 1, 1995
INR reporting in Canadian medical laboratories. Thrombosis Interest Group of CanadaM Andrew, M Brigden, J Bormanis, et al.
Chest|November 20, 1998
Prevention of venous thromboembolismG P Clagett, F A Anderson, W Geerts, et al.
Thrombosis and Haemostasis|August 1, 1995
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosisM N Levine, J Hirsh, M Gent, et al.
Intensive Care Medicine|December 14, 2004
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patientsM A Crowther, D J Cook, L E Griffith, et al.
Annals of Internal Medicine|September 1, 1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind studyA G Turpie, M Gent, R Côte, et al.
The New England Journal of Medicine|November 18, 2000
Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study GroupP Brill-Edwards, J S Ginsberg, M Gent, et al.
The Review of Scientific Instruments|March 3, 2012
Microgan electron cyclotron resonance ion source in a Van de Graaff accelerator terminalG Gaubert, C Bieth, W Bougy, et al.
Journal of Thrombosis and Haemostasis : JTH|July 6, 2010
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant gliomaJ R Perry, J A Julian, N J Laperriere, et al.
Journal of Thrombosis and Haemostasis : JTH|March 1, 2005
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosisS R Kahn, C Kearon, J A Julian, et al.
Pageof 3